Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia

David P. Rotella, Geraldine R. McFarlane, Alexander Greenfield, Cristina Grosanu, Albert J. Robichaud, Rajiah Aldrin Denny, Rolf W. Feenstra, Sara Núñez-García, Jan Hendrik Reinders, Martina van der Neut, Andrew McCreary, Chris G. Kruse, Kelly Sullivan, Farhana Pruthi, Margaret Lai, Jean Zhang, Dianne M. Kowal, Tikva Carrick, Steven M. Grauer, Rachel L. NavarraRadka Graf, Julie Brennan, Karen L. Marquis, Mark H. Pausch

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint Dive into the research topics of 'Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D<sub>2</sub> partial agonists for the potential treatment of schizophrenia'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences